Virion Display: A High-Throughput Method to Express Functional Membrane Proteins.

Area of Science:

• Biochemistry
• Molecular Biology
• Virology

Background:

• Transmembrane proteins perform vital cellular roles and are key drug targets.
• Studying transmembrane proteins, particularly multipass types, is challenging due to their need for a lipid bilayer environment.
• Existing methods struggle to maintain the native conformation of these proteins for effective research.

Purpose of the Study:

• To present a standardized protocol for integrating transmembrane proteins into the herpes simplex virus 1 (HSV-1) envelope using Virion Display (VirD) technology.
• To enable the production of recombinant HSV-1 virions displaying functional transmembrane proteins for biological and pharmaceutical applications.
• To facilitate the study of challenging protein targets, including G-protein-coupled receptors.

Main Methods:

• Integration of transmembrane protein open reading frames into the HSV-1 genome.
• Production of recombinant HSV-1 virions using established molecular biology techniques.
• Purification of VirD virions for downstream analysis and experimentation.

Main Results:

• Successful integration of diverse transmembrane proteins, including G-protein-coupled receptors, into the HSV-1 viral envelope.
• Generation of pure VirD virions displaying specific and functional transmembrane proteins.
• Demonstration of VirD technology's applicability to a large set of human transmembrane proteins.

Conclusions:

• VirD technology provides a robust platform for studying transmembrane proteins in a native-like conformation.
• This method overcomes previous limitations in transmembrane protein research and drug target identification.
• The described protocols enable the production of valuable tools for pharmaceutical and biological investigations.